Jan 24, 2024, 22:11
Jean-Charles Soria: Delving into the future of cancer treatment with new ADC formats
Jean-Charles Soria, Senior Vice President of Oncology within Global Development at Amgen, posted the following on LinkedIn:
“Delving into the future of cancer treatment with new ADC formats: Bispecific ADCs targeting multiple antigens, Dual-drug ADCs combining different cytotoxins, Probody-drug conjugates for enhanced tumor specificity, Immune-stimulating ADCs, Protein-degrader ADCs & other formats pushing the frontiers of oncology.”
Read further.
Source: Jean-Charles Soria/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 13:53
Dec 2, 2024, 13:02
Dec 2, 2024, 12:44
Dec 2, 2024, 12:39